Publication | Open Access

Discovery of Ipragliflozin (ASP1941): A novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus

Medicinal ChemistryBiochemistryBenzothiophene StructureMedicineDiabetesGlycobiologyType 2Natural SciencesPharmacological AgentSelective SodiumDiabetes MellitusPharmacologyDrug Discovery